Carl P. Sherr & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.36M Sell
5,494
-9
-0.2% -$10.6K 2.73% 9
2026
Q2
$6.6M Buy
5,503
+420
+8% +$429K 2.77% 7
2026
Q1
$4.68M Hold
5,083
– – 2.2% 10
2025
Q4
$5.27M Sell
5,083
-100
-2% -$95.6K 2.35% 10
2025
Q3
$3.95M Sell
5,183
-140
-3% -$104K 1.87% 14
2025
Q2
$4.15M Sell
5,323
-210
-4% -$163K 2.1% 10
2025
Q1
$4.57M Hold
5,533
– – 2.5% 8
2024
Q4
$4.27M Buy
5,533
+7
+0.1% +$5.8K 2.24% 9
2024
Q3
$4.9M Buy
5,526
+24
+0.4% +$21.6K 2.58% 7
2024
Q2
$4.98M Buy
5,502
+211
+4% +$169K 2.78% 7
2024
Q1
$4.12M Sell
5,291
-26
-0.5% -$18.5K 2.32% 8
2023
Q4
$3.1M Sell
5,317
-556
-9% -$325K 1.88% 10
2023
Q3
$3.15M Sell
5,873
-20
-0.3% -$10.3K 2.14% 9
2023
Q2
$2.76M Hold
5,893
– – 1.81% 10
2023
Q1
$2.02M Hold
5,893
– – 1.45% 18
2022
Q4
$2.16M Sell
5,893
-147
-2% -$52.1K 1.64% 15
2022
Q3
$1.95M Hold
6,040
– – 1.56% 14
2022
Q2
$1.96M Buy
6,040
+115
+2% +$34.5K 1.47% 14
2022
Q1
$1.7M Sell
5,925
-333
-5% -$85.7K 1.15% 20
2021
Q4
$1.73M Sell
6,258
-328
-5% -$83.1K 1.05% 23
2021
Q3
$1.52M Sell
6,586
-10
-0.2% -$2.47K 1.21% 22
2021
Q2
$1.51M Sell
6,596
-75
-1% -$15.1K 1.04% 24
2021
Q1
$1.25M Sell
6,671
-62
-0.9% -$12.1K 0.94% 27
2020
Q4
$1.14M Hold
6,733
– – 0.91% 27
2020
Q3
$997K Hold
6,733
– – 0.9% 27
2020
Q2
$1.1M Sell
6,733
-187
-3% -$28.7K 1.1% 21
2020
Q1
$960K Sell
6,920
-546
-7% -$75K 1.14% 23
2019
Q4
$981K Buy
+7,466
New +$865K 0.96% 31

Other funds holding LLY

Carl P. Sherr & Co's LLY Position: Q3 2026 in Review

Carl P. Sherr & Co reduced its Eli Lilly (LLY) stake by 0.16% in Q3 2026, selling an estimated $10.6K and leaving 5,494 shares worth $6.36M. The position accounts for 2.73% of the portfolio, ranked #9.

Carl P. Sherr & Co first reported a position in LLY in Q4 2019 and has held it in 28 quarters since. The position peaked at $6.6M in Q2 2026. 3,289 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Carl P. Sherr & Co held 5,494 shares of Eli Lilly worth $6.36M as of Q3 2026.
  • Carl P. Sherr & Co sold 9 Eli Lilly shares in Q3 2026, an estimated $10.6K.
  • Eli Lilly made up 2.73% of Carl P. Sherr & Co's portfolio in Q3 2026, its #9 holding.
  • Carl P. Sherr & Co first reported a position in Eli Lilly in Q4 2019 and has held it in 28 quarters since.
  • Carl P. Sherr & Co's Eli Lilly position peaked at $6.6M in Q2 2026.
  • 3,289 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Carl P. Sherr & Co's 13F filing for Q3 2026, filed 6 Nov 2026.